Onyx Biotec (NSE:ONYX) Beginning Cash Position: ₹0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ONYX Onyx Biotec Ltd NSE:ONYX
13 GF Score
Price ₹44.65
! 9 Warning Signs
View Full Analysis

What is Onyx Biotec Beginning Cash Position?

Onyx Biotec NSE:ONYX +2.17% 13 Beginning Cash Position is ₹0.0 Mil as of Mar. 2026. GuruFocus rates NSE:ONYX with a GF Score™ of 13/100. The stock has 9 warning signs investors should review.

Onyx Biotec's Beginning Cash Position for the quarter that ended in Mar. 2026 was ₹0.0 Mil.

Onyx Biotec's quarterly Beginning Cash Position increased from Mar. 2025 (₹0.0 Mil) to Sep. 2025 (₹86.1 Mil) but then declined from Sep. 2025 (₹86.1 Mil) to Mar. 2026 (₹0.0 Mil).

Onyx Biotec's annual Beginning Cash Position increased from Mar. 2024 (₹0.1 Mil) to Mar. 2025 (₹14.7 Mil) and increased from Mar. 2025 (₹14.7 Mil) to Mar. 2026 (₹86.1 Mil).

Onyx Biotec Beginning Cash Position Related Terms

Onyx Biotec Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Onyx Biotec's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onyx Biotec Beginning Cash Position Chart

Onyx Biotec Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Beginning Cash Position
1.06 -42.70 0.07 14.67 86.12

Onyx Biotec Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Beginning Cash Position Get a 7-Day Free Trial 0.00 0.00 0.00 86.10 0.02
NSE:ONYX
13GF Score
Onyx Biotec Ltd NSE:ONYX
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onyx Biotec Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of ₹0.0 Mil mean?
Onyx Biotec (NSE:ONYX) has a Beginning Cash Position of ₹0.0 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Onyx Biotec and its competitors.
Is Onyx Biotec's Beginning Cash Position too high?
Onyx Biotec's current Beginning Cash Position is ₹0.0 Mil. Overall, Onyx Biotec has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Onyx Biotec's Beginning Cash Position compare to ISRG and BDX?
Onyx Biotec's Beginning Cash Position of ₹0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Onyx Biotec and its competitors. Onyx Biotec's current Beginning Cash Position is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Biotec stock overvalued right now?
Onyx Biotec (NSE:ONYX) has a current Beginning Cash Position of ₹0.0 Mil. The current Beginning Cash Position is ₹0.0 Mil. Onyx Biotec's overall GF Score™ is 13/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Onyx Biotec (NSE:ONYX), the current Beginning Cash Position is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Onyx Biotec Business Description

Address Nalagarh Road, Near Sainimajraropar, Village Bir Plassi, Solan, HP, IND, 174101
Onyx Biotec Ltd is engaged in healthcare segment and offering Sterile Pharmaceutical products ,and acts as a pharmaceutical contract manufacturer. It offering products such as Sterile Water for Injections, Dry Powder Injections and Dry Syrup for India and overseas. Key revenue is generated from Sterile Water for Injections .
13GF Score

Get the complete analysis for NSE:ONYX

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹44.65
Price